BACKGROUND: Takayasu's arteritis (TA) is a chronic granulomatous inflammatory vasculitis of unknown etiology that affects large arteries, especially the aortic arch and its branches, and ...
BACKGROUND: Ustekinumab (UST)is a fully human monoclonal antibody against IL-12/23 approved in Brazil for the treatment of moderate-to-severe Crohn’s disease (CD) in November 2017. UST ha...
BACKGROUND: Ustekinumab (UST)is a fully human monoclonal antibody against IL-12/23 approved in Brazil for the treatment of moderate-to-severe Crohn’s disease (CD) in November 2017. U...
BACKGROUND: Despite the decline in the incidence of Tuberculosis (TB) worldwide, this disease still causes high rates of morbimortality. It is estimated that TB caused 1.3 million deaths ...
BACKGROUND: Comorbidities among immune mediated inflammatory disorders are frequently reported (1). Although some physicians are not aware of the potential association between autoimmune ...
BACKGROUND: The main ophthalmologic extraintestinal manifestations (EIM) in inflammatory bowel disease (IBD) patients are episcleritis, uveitis and scleritis. Uncommon ophtalmic involveme...
BACKGROUND: Crohn's disease (CD) is a chronic inflammatory disease that can affect all segments of the gastrointestinal tract. With various phenotypes and progressive course, it can ...
BACKGROUND: Crohn's disease (CD) is a chronic inflammatory disease that can affect all segments of the gastrointestinal tract. With various phenotypes and progressive course, it can be co...
BACKGROUND: Takayasu's arteritis (TA) is a chronic granulomatous inflammatory vasculitis of unknown etiology that affects large arteries, especially the aortic arch and its branches,...